Loading…
AstraZeneca announced a $50 billion investment in the US by 2030, including a new multi-billion dollar drug substance manufacturing centre in Virginia for weight management and metabolic medicines.
“AstraZeneca today announces $50 billion of investment in the United States by 2030, building on America's global leadership in medicines manufacturing and R&D.”astrazeneca.com
Summarized from public sources; check the original articles before acting on it.